ArticleThe Journal of urology2018

Re: Intravesical rAd-IFNα/Syn3 for Patients with High-Grade, bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.

Sam S ChangPubMed ↗Publisher ↗

No numbers read from the abstract.